([13C₆]Leu17)-Thymosin β4 (human, bovine, horse, rat) is a stable isotope-labeled variant of thymosin β4, featuring a carbon-13 enriched leucine at position 17. This modification allows detailed tracking of thymosin's interaction with actin and its role in cell migration. The labeled peptide supports NMR and mass spectrometry analyses in structural biology. Researchers use it to explore actin-binding dynamics and cell motility in various species.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More